Jennifer Stevens - 11 Mar 2026 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Mar 2026, 16:25:34 UTC
Prior SEC filing
25 Nov 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Mary Szela, Attorney-in-Fact

Key filing fact

Jennifer Stevens filed Form 4 for TriSalus Life Sciences, Inc. (TLSI) on 20 Mar 2026.

Key facts

  • This page summarizes Jennifer Stevens's Form 4 filing for TriSalus Life Sciences, Inc. (TLSI).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Mar 2026, 16:25.

Change

  • Previous filing in this sequence was filed on 25 Nov 2025.
  • Current net transaction value: -$14,509.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001982621 Primary reporting owner

Stevens Jennifer

Relationship
Chief Regulatory Officer
Address
6272 W. 91ST AVENUE, WESTMINSTER
Signature
/s/ Mary Szela, Attorney-in-Fact
Signature date
20 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TLSI transaction

Common Stock

Sale

Transaction value
$4,973
Shares
-1,204
Change %
-0.94%
Price
$4.13
Shares after
126,436
Date
11 Mar 2026
Ownership
Direct
Footnotes
F1
TLSI transaction

Common Stock

Sale

Transaction value
$6,348
Shares
-1,552
Change %
-1.2%
Price
$4.09
Shares after
124,884
Date
12 Mar 2026
Ownership
Direct
Footnotes
F1
TLSI transaction

Common Stock

Sale

Transaction value
$3,189
Shares
-774
Change %
-0.62%
Price
$4.12
Shares after
124,110
Date
16 Mar 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares sold to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person. This transaction does not represent a discretionary sale by the reporting person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .